Shanghai Weishen Pharmaceutical
Innovative pharmaceutical solutions enhancing patient care through cutting-edge research and development
About Shanghai Weishen Pharmaceutical
WV Pharm is a pioneering pharmaceutical company dedicated to advancing patient care through innovative research and development. The company operates in the healthcare and pharmaceutical market, focusing on creating new and effective medications that address unmet medical needs. WV Pharm serves a diverse range of clients, including hospitals, clinics, and individual patients, providing them with high-quality pharmaceutical products. The business model revolves around extensive research and development, clinical trials, and the subsequent commercialization of new drugs. Revenue is generated through the sale of these medications to healthcare providers and patients. The company also invests in partnerships and collaborations with other healthcare entities to expand its product offerings and market reach.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 19.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2025 | — | — | Undisclosed | ↗ |
| SEED✓Equity / VC | Dec 2021 | $14M | $55M | Rongsheng Venture Capital · Zhangke Herun Venture Capital · Wenzhou Investment | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Weishen Pharmaceutical in the Wuhan ecosystem
The Shanghai Weishen Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- ZCZhangke Herun Venture Capital
- WIWenzhou Investment
- RCRongsheng Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Weishen Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Weishen Pharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








